These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11755345)

  • 1. Synthesis and biological activity of 8beta-substituted hydrocodone indole and hydromorphone indole derivatives.
    Yu H; Prisinzano T; Dersch CM; Marcus J; Rothman RB; Jacobson AE; Rice KC
    Bioorg Med Chem Lett; 2002 Jan; 12(2):165-8. PubMed ID: 11755345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
    Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
    J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy.
    McLamore S; Ullrich T; Rothman RB; Xu H; Dersch C; Coop A; Davis P; Porreca F; Jacobson AE; Rice KC
    J Med Chem; 2001 Apr; 44(9):1471-4. PubMed ID: 11311071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and delta-opioid receptor antagonist activity of a naltrindole analogue with a regioisomeric indole moiety.
    Portoghese PS; Ohkawa S; Moe ST; Takemori AE
    J Med Chem; 1994 Jun; 37(12):1886-8. PubMed ID: 8021929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands.
    Fang X; Larson DL; Portoghese PS
    J Med Chem; 1997 Sep; 40(19):3064-70. PubMed ID: 9301669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. delta Opioid affinity and selectivity of 4-hydroxy-3-methoxyindolomorphinan analogues related to naltrindole.
    Coop A; Rothman RB; Dersch C; Partilla J; Porreca F; Davis P; Jacobson AE; Rice KC
    J Med Chem; 1999 May; 42(9):1673-9. PubMed ID: 10229636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of tripeptides containing D-Trp substituted at the indole ring, assessment of opioid receptor binding and in vivo central antinociception.
    De Marco R; Bedini A; Spampinato S; Gentilucci L
    J Med Chem; 2014 Aug; 57(15):6861-6. PubMed ID: 25051243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid binding and in vitro profiles of a series of 4-hdroxy-3-methoxyindolomorphinans. Transformation of a delta-selective ligand into a high affinity kappa-selective ligand by introduction of a 5,14-substituted bridge.
    Grundt P; Martinez-Bermejo F; Lewis JW; Husbands SM
    J Med Chem; 2003 Jul; 46(14):3174-7. PubMed ID: 12825957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry.
    Smith ML; Hughes RO; Levine B; Dickerson S; Darwin WD; Cone EJ
    J Anal Toxicol; 1995; 19(1):18-26. PubMed ID: 7536861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydromorphone and hydrocodone interference in GC/MS assays for morphine and codeine.
    Fenton J; Mummert J; Childers M
    J Anal Toxicol; 1994; 18(3):159-64. PubMed ID: 7520516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
    Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
    Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological synthesis of the analgesic hydromorphone, an intermediate in the metabolism of morphine, by Pseudomonas putida M10.
    Hailes AM; Bruce NC
    Appl Environ Microbiol; 1993 Jul; 59(7):2166-70. PubMed ID: 7689317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14 beta-[(p-nitrocinnamoyl)amino]morphinones, 14 beta-[(p-nitrocinnamoyl)amino]-7,8-dihydromorphinones, and their codeinone analogues: synthesis and receptor activity.
    Sebastian A; Bidlack JM; Jiang Q; Deecher D; Teitler M; Glick SD; Archer S
    J Med Chem; 1993 Oct; 36(21):3154-60. PubMed ID: 7693944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probes for narcotic receptor-mediated phenomena. 20. Alteration of opioid receptor subtype selectivity of the 5-(3-hydroxyphenyl)morphans by application of the message-address concept: preparation of delta-opioid receptor ligands.
    Bertha CM; Flippen-Anderson JL; Rothman RB; Porreca F; Davis P; Xu H; Becketts K; Cha XY; Rice KC
    J Med Chem; 1995 Apr; 38(9):1523-37. PubMed ID: 7739011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo activity of norhydrocodone: an active metabolite of hydrocodone.
    Navani DM; Yoburn BC
    J Pharmacol Exp Ther; 2013 Nov; 347(2):497-505. PubMed ID: 23995596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoration of the aromatic ring of dihydrocodeinone (hydrocodone) and 14-hydroxydihydrocodeinone (oxycodone).
    Wilson ML; Carroll PJ; Dalton DR
    J Org Chem; 2005 Aug; 70(16):6492-5. PubMed ID: 16050714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.
    Faust R; Garratt PJ; Jones R; Yeh LK; Tsotinis A; Panoussopoulou M; Calogeropoulou T; Teh MT; Sugden D
    J Med Chem; 2000 Mar; 43(6):1050-61. PubMed ID: 10737738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.